Vladonix is a thymus-targeting bioregulator peptide renowned for its ability to counteract age-related thymic involution. By restoring peptide signalling within thymic tissue, it supports T-cell education, immune repertoire diversity, and the body's adaptive defence capacity.
Vladonix is a precision-engineered bioregulator peptide that selectively targets thymus through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within thymus cells, Vladonix helps normalise thymic involution reversal and T-cell repertoire diversity—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for immune tissue maintenance, making it a fundamentally different approach from conventional supplementation.